Company News

Share this article:

Contract sales firm PDI announced new business wins exceeding $18 million, but would not divulge the new clients' names, based on contractual agreements, according to a spokesperson. The contracts include primary care, specialty and hospital settings sales teams, according to a statement. Reps will be deployed in June, and will call on hospital-based physicians specializing in women's health, primary care and pediatrics.

 

Eloquest Healthcare, a dermatology specialty company, partnered with Onset Therapeutics to market Optase, a topical prescription product for the treatment of decubitus ulcers, varicose ulcers and dehiscent wounds. Optase is one of two products joint-marketed by Onset Therapeutics and Eloquest Healthcare – the second is Exactacain, a topical anesthetic spray.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.